ReviewEuropean urology open science2022
Current Management of Urachal Carcinoma: An Evidence-based Guide for Clinical Practice.
Review in European urology open science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
27 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma.Frontiers in pharmacology · 2023Pooled it
- ASO Author Reflections: Surgical Management of Urachal Cancer in Germany: A Nationwide Analysis from 2006 to 2022.Annals of surgical oncology · 2026Article
- Surgical Management of Urachal Cancer in Germany: A Nationwide Analysis From 2006 to 2022.Annals of surgical oncology · 2026Article
- Clinical landscape of urachal carcinoma: a two-decade real-world study.International journal of surgery (London, England) · 2026Article
- Clinical and imaging predictors of urachal carcinoma: the role of gross hematuria and calcification in a single-center retrospective study.BMC urology · 2026Article
- Urachal Signet Ring Cell Carcinoma: A Clinicopathological Analysis of 28 Cases.Current oncology (Toronto, Ont.) · 2026Article
- Patient-derived d-MMR/MSI phenotype urachal cancer organoids for personalized drug screening.Frontiers in oncology · 2026Article
- A case of neuroendocrine carcinoma of the urachal cancer with comprehensive genomic profiling results.International cancer conference journal · 2026Article
- Signet-Ring Cell Type Adenocarcinoma of the Urachus: A Rare Case.Clinical case reports · 2025Article
- Case report: Fistula formation of a urachal cyst 6 years after prostatectomy.Urology case reports · 2025Article
- Infected urachal remnant presenting with purulent umbilical discharge in an adult: A diagnostic and surgical challenge.Urology case reports · 2025Article
- Article
- Long-Term Survival Obtained by Repeated Cytoreductive Surgery and S-1 Plus Cisplatin Chemotherapy at Each Instance of Disease Progression in a Patient With Metastatic Urachal Carcinoma: A Case Report.Cancer reports (Hoboken, N.J.) · 2025Article
- Primary urachal adenocarcinoma treated with partial cystectomy - Case report.International journal of surgery case reports · 2025Article
- Robot-Assisted Urachal Excision and Partial Cystectomy for Urachal Pathologies: Systematic Review with Insights from Single-Center Experience.Journal of clinical medicine · 2025Review
- Comprehensive analysis of targetable mutations and tumor microenvironment in urachal cancer.NPJ precision oncology · 2025Article
- A case-based review of urachal carcinoma with mixed small cell neuroendocrine and adenocarcinoma components, with one new case report and analysis of nine published cases.Frontiers in endocrinology · 2025Review
- Article
- Urachal adenocarcinoma in an adolescent boy: a case report.BMC pediatrics · 2024Article
- Regular gastroscopy and colonoscopy during the evaluation of urachal cancer: do we really need them?BMC cancer · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Urachal carcinoma is a rare urological disease. The shortage of data about diagnosis and surgical treatment in literature makes it hard for clinicians to make a decision. Indeed, urachal carcinoma is an aggressive disease that requires prompt staging and treatment to ensure the best outcome for patients. We reviewed the last evidence about the management of urachal carcinoma to provide an easy-to-use guide for clinical practice. Patient summary: Urachal carcinoma is a rare malignancy. The literature on this challenging disease remains limited. Herein, we provide a practical guide for its management from diagnosis to treatment, which in most cases requires surgical intervention or chemotherapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.